The recombinant human G-CSF (rh-GCSF)was expressed in engineered E. coli and affirmed inchemotherapy-induced neutropenia by the U.S Food andDrug Administration (FDA) in 1991 for clinical usage (5). Here, CSF3 is linked to neutropenia.